APPLICATION OF THE DOCETEXELA FOR THE TREATMENT OF HEPATIC AND CELLULAR CANCER

摘要

The present invention is based on the discovery that docetaxel is significantly more potent to hepatocellular cancer cells than paclitaxel, in concentrations up to 1 μM. Accordingly, it suggests the use of docetaxel or its hydrate in the manufacture of drugs for use in the treatment of hepatocellular carcinoma. The international search report was published 2001.09.20.